# Memantine Treatment Study of Pathological Gambling

> **NCT00585169** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 29 (actual)

## Conditions studied

- Pathological Gambling

## Interventions

- **DRUG:** Memantine Hydrochloride

## Key facts

- **NCT ID:** NCT00585169
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585169, "Memantine Treatment Study of Pathological Gambling". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00585169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*